SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 43 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,640,933 | -68.9% | 2,681,000 | -69.1% | 0.03% | -70.3% |
| Q3 2022 | $8,482,000 | +0.6% | 8,681,000 | 0.0% | 0.09% | +8.3% |
| Q2 2022 | $8,429,000 | -5.6% | 8,681,000 | -4.3% | 0.08% | -3.4% |
| Q1 2022 | $8,928,000 | -9.4% | 9,071,000 | -8.7% | 0.09% | -5.4% |
| Q4 2021 | $9,858,000 | -39.6% | 9,940,000 | -39.9% | 0.09% | -34.8% |
| Q3 2021 | $16,325,000 | -29.4% | 16,540,000 | -29.3% | 0.14% | -19.9% |
| Q2 2021 | $23,120,000 | +1.8% | 23,405,000 | 0.0% | 0.18% | -8.3% |
| Q1 2021 | $22,701,000 | +1.9% | 23,405,000 | 0.0% | 0.19% | +17.1% |
| Q4 2020 | $22,278,000 | +15.5% | 23,405,000 | +12.0% | 0.16% | -4.1% |
| Q3 2020 | $19,286,000 | +3.8% | 20,905,000 | 0.0% | 0.17% | -8.6% |
| Q2 2020 | $18,582,000 | +8.6% | 20,905,000 | 0.0% | 0.19% | -24.6% |
| Q1 2020 | $17,104,000 | +35.9% | 20,905,000 | +51.1% | 0.25% | +69.9% |
| Q4 2019 | $12,587,000 | – | 13,838,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|